Refreshing results…
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
UploadSearch for AL amyloidosis risk factors using Mendelian randomization
Download from doi.orgInternational Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Download from www.nature.comMissing publications? Search for publications with a matching author name.